<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(11)</volume><submitter>McCune E</submitter><funding>Breast Cancer Research Foundation (BCRF)</funding><funding>Breast Cancer Research Foundation</funding><funding>California Breast Cancer Research Program</funding><funding>California Breast Cancer Research Program (CBCRP)</funding><pubmed_abstract>This study characterized and compared the fecal and oral microbiota from women with early-stage breast cancer (BC), women with ductal carcinoma &lt;i>in situ&lt;/i> (DCIS), and healthy women. Fecal and oral samples were collected from newly diagnosed patients prior to any therapy and characterized using 16S rRNA sequencing. Measures of gut microbial alpha diversity were significantly lower in the BC vs healthy cohort. Beta diversity differed significantly between the BC or DCIS and healthy groups, and several differentially abundant taxa were identified. Clustering (non-negative matrix factorization) of the gut microbiota identified five bacterial guilds dominated by &lt;i>Prevotella&lt;/i>, Enterobacteriaceae, &lt;i>Akkermansia&lt;/i>, Clostridiales, or &lt;i>Bacteroides&lt;/i>. The &lt;i>Bacteroides&lt;/i> and Entero</pubmed_abstract><journal>mSystems</journal><pagination>e0123724</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11575313</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma &amp;lt;i&amp;gt;in situ&amp;lt;/i&amp;gt;, and healthy women.</pubmed_title><pmcid>PMC11575313</pmcid><pubmed_authors>Heditsian D</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>O'Meara T</pubmed_authors><pubmed_authors>Brain S</pubmed_authors><pubmed_authors>McCune E</pubmed_authors><pubmed_authors>Theiner S</pubmed_authors><pubmed_authors>Esserman L</pubmed_authors><pubmed_authors>Johnson B</pubmed_authors><pubmed_authors>Campos M</pubmed_authors><pubmed_authors>Campbell MJ</pubmed_authors><pubmed_authors>Gilbert JA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma &amp;lt;i&amp;gt;in situ&amp;lt;/i&amp;gt;, and healthy women.</name><description>This study characterized and compared the fecal and oral microbiota from women with early-stage breast cancer (BC), women with ductal carcinoma &lt;i>in situ&lt;/i> (DCIS), and healthy women. Fecal and oral samples were collected from newly diagnosed patients prior to any therapy and characterized using 16S rRNA sequencing. Measures of gut microbial alpha diversity were significantly lower in the BC vs healthy cohort. Beta diversity differed significantly between the BC or DCIS and healthy groups, and several differentially abundant taxa were identified. Clustering (non-negative matrix factorization) of the gut microbiota identified five bacterial guilds dominated by &lt;i>Prevotella&lt;/i>, Enterobacteriaceae, &lt;i>Akkermansia&lt;/i>, Clostridiales, or &lt;i>Bacteroides&lt;/i>. The &lt;i>Bacteroides&lt;/i> and Entero</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T20:38:47.882Z</modification><creation>2025-04-04T20:38:47.882Z</creation></dates><accession>S-EPMC11575313</accession><cross_references><pubmed>39470189</pubmed><doi>10.1128/msystems.01237-24</doi></cross_references></HashMap>